Jeff Hinton to Leave MedCath
June 05 2009 - 4:05PM
PR Newswire (US)
Art Parker Named Interim Chief Financial Officer CHARLOTTE, N.C.,
June 5 /PRNewswire-FirstCall/ -- MedCath Corporation (NASDAQ:MDTH),
a healthcare provider focused on high acuity healthcare services,
predominately the diagnosis and treatment of cardiovascular
disease, today announced that Art Parker, Senior Vice President,
Finance and Development, has been named Interim Chief Financial
Officer. Parker replaces Jeff Hinton, whose employment with MedCath
has ended effective immediately. "Art has been a long-time
participant as a member of senior management and is well-known to
the investor community, banking community, and throughout MedCath
as a very capable financial manager," said Ed French, MedCath's
President and Chief Executive Officer. "He is very much engaged in
all of our assets and has worked closely over the past years with
our very capable accounting and finance team. I'm delighted to have
him step up and provide leadership as Interim CFO." MedCath has
engaged an executive search firm to identify a permanent Chief
Financial Officer candidate. MedCath Corporation, headquartered in
Charlotte, N.C., is a healthcare provider focused on high acuity
services with the diagnosis and treatment of cardiovascular disease
being a primary service offering. MedCath owns an interest in and
operates nine hospitals with a total of 755 licensed beds, located
in Arizona, Arkansas, California, Louisiana, New Mexico, South
Dakota, and Texas. MedCath is in the process of developing its
tenth hospital, which is anticipated to open in fall 2009, in
Kingman, Ariz. In addition, MedCath and its subsidiary MedCath
Partners provide services in diagnostic and therapeutic facilities
in various states. DATASOURCE: MedCath Corporation CONTACT: O.
Edwin French, President & Chief Executive Officer, MedCath
Corporation, +1-704-708-6600
Copyright
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024